IdentifySensors Biologics | The New Check4 Cancer Test

Check4® is being developed to detect mutations associated with treatment response and resistance, beginning with EGFR and KRAS in non-small cell lung cancer (NSCLC). The platform is intended to complement broader genomic testing by making focused, repeated mutation testing more practical in clinical laboratories. Future panels are planned for additional precision oncology gene targets, gene fusions, and other molecular biomarkers. #technology #medical #ISB #medtech #diagnostics